Zenarestat -: Treatment of diabetic neuropathy aldose reductase inhibitor

被引：0

|

作者：

不详

机构：

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：104 / 105

页数：2

相关论文

共 50 条

[41] CRANIAL NERVE NEUROPATHY OF DIABETIC RATS IS PREVENTED BY TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR
NOTVEST, RR
INSERRA, JJ
KEIM, KL
DIABETES, 1986, 35 : A206 - A206
[42] RECENT ADVANCES IN THE THERAPY OF DIABETIC PERIPHERAL NEUROPATHY BY MEANS OF AN ALDOSE REDUCTASE INHIBITOR
GREENE, DA
LATTIMER, SA
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (5A): : 13 - 17
[43] A CONTROLLED TRIAL OF SORBINIL, AN ALDOSE REDUCTASE INHIBITOR, IN CHRONIC PAINFUL DIABETIC NEUROPATHY
YOUNG, RJ
EWING, DJ
CLARKE, BF
DIABETES, 1983, 32 (10) : 938 - 942
[44] Long term treatment with ranirestat, an aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats
Matsumoto, Takafumi
Toyosawa, Kaoru
Furutani, Yasur
Bril, Vera
DIABETES, 2006, 55 : A125 - A125
[45] An aldose reductase inhibitor ameliorates diabetic autonomic neuropathy in type 2 diabetic subjects.
Nakamura, J
Nakayama, M
Hamada, Y
Chaya, S
Kato, K
Kasuya, Y
Mizubayashi, R
Miwa, K
Yasuda, Y
Kamiya, H
Hotta, N
DIABETOLOGIA, 1999, 42 : A293 - A293
[46] Aldose reductase inhibition in the treatment of diabetic neuropathy: Where are we in 2004?
Gabbay K.H.
Current Diabetes Reports, 2004, 4 (6) : 405 - 408
[47] THE ROLE OF ALDOSE REDUCTASE INHIBITORS IN THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY - REPLY
YUE, DK
BROOKS, B
MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (01) : 45 - 45
[48] Dose-related effects of the aldose reductase inhibitor Zenarestat on nerve sorbitol levels, nerve conduction velocity and nerve fiber density in human diabetic neuropathy.
Greene, D
Arezzo, J
Brown, M
DIABETES, 1996, 45 : 9 - 9
[49] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, SORBINIL, ON EXPERIMENTAL DIABETIC NEUROPATHY AND SUGAR CATARACTS IN RATS
ISHIKO, J
SUZUKI, M
OHTSUKI, I
JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P244 - P244
[50] WITHDRAWAL OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT IN PATIENTS WITH DIABETIC NEUROPATHY - EFFECT ON NERVE FUNCTION
SANTIAGO, JV
SONKSEN, PH
BOULTON, AJM
MACLEOD, A
BEG, M
BOCHENEK, W
GRAEPEL, GJ
GONEN, B
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1993, 7 (03) : 170 - 178

← 1 2 3 4 5 →